Portal de Periódicos da CAPES

Iron deficiency in chronic kidney disease patients with diabetes mellitus

2018; Elsevier BV; Volume: 12; Issue: 6 Linguagem: Inglês

10.1016/j.dsx.2018.05.018

1878-0334

Nicolás Roberto Robles, Juan Lucio Ramos, Edgar Chávez, Boris Gonzalez Candia, Miguel Ángel Bayo, Antonio Cidoncha, Juan López Gómez, Juan José Cubero,

Hemoglobinopathies and Related Disorders

Iron deficiency has been studied extensively in patients with chronic kidney disease on hemodialysis therapy. However, few studies looked at iron treatment in the non-dialysis chronic kidney disease population.Five hundred and eighty patients were studied (247 were diabetic persons). Patients were divided into 4 groups: non-diabetic subjects without CKD, non-diabetic ones with GFR < 60 mL/min, diabetic persons without CKD and diabetic ones with GFR < 60 mL/min). Iron deficiency was diagnosed when serum ferritin level was <100 mg/dl. It was defined as diminished iron availability when ferritin was above 100 mg/dl and serum transferrin saturation (TSAT) was <20%.Anemia was more frequent in the diabetic CKD patients group (52.4%, p < 0.001). Anemia prevalence was also higher in all CKD patients as well as in diabetic patients compared with non-diabetic ones. Iron deficiency was more frequent in diabetic patients. Among CKD diabetic patients the prevalence of iron deficiency was higher than in non-diabetic CKD ones. Diminished iron availability prevalence was higher in non-diabetic patients. Logistic regression analysis showed that only sex and diabetes mellitus were independently associated with iron deficiency.Anemia was more common in diabetic CKD patients. Diabetes mellitus was independently associated with iron deficiency. Surprisingly, diminished iron availability was not more frequent in diabetic patients. The physio-pathological mechanisms that could explain these findings remain to be elucidated.